# OnCo record rp-3467 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/rp-3467/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "rp-3467" ;
  schema:name "RP-3467"@en ;
  schema:description "RP-3467 is an experimental small molecule enzyme inhibitor from Repare Therapeutics, in phase 1 trials for epithelial ovarian cancer, metastatic breast cancer and metastatic castration-resistant prostate cancer and other cancers; its current status is not stated."@en ;
  schema:url <https://onco.cc/drugs/rp-3467/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1808158/000119312525159942/d944012dex991.htm>, <https://www.sec.gov/Archives/edgar/data/1808158/000119312525283314/d39095dex991.htm>, <https://clinicaltrials.gov/api/v2/studies/NCT06560632>, <https://clinicaltrials.gov/search?intr=RP-3467> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule enzyme inhibitor" ;
  onco:targets <https://onco.cc/targets/polq/> ;
  onco:companies <https://onco.cc/companies/repare-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06560632/> .
